TY - JOUR T1 - Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period JF - BMJ Case Reports JO - BMJ Case Reports DO - 10.1136/bcr-2020-234335 VL - 13 IS - 5 SP - e234335 AU - Ariana Patras AU - Reinaldo Figueroa AU - Amit P Singh AU - Ichchha Madan Y1 - 2020/05/01 UR - http://casereports.bmj.com/content/13/5/e234335.abstract N2 - We present a case of a pregnant woman with chronic immune thrombocytopenic purpura and chronic hypertension who developed pre-eclampsia with severe features warranting delivery. Her overall clinical picture and liver enzymes improved in the immediate postpartum period, however, aggressively progressing thrombocytopenia posed a diagnostic dilemma to the interdisciplinary care team. After failing to respond to first-line therapies including high-dose corticosteroids and intravenous immunoglobulin, she was successfully managed with a trial of the thrombopoietin receptor agonist, Romiplostim. ER -